Liau, Linda M <br/><br/>
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.  [electronic resource] 

 -  Journal of translational medicine  05 2018 
 - 142 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/s12967-018-1507-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Brain Neoplasms--diagnosis<br/>Cancer Vaccines--adverse effects<br/>Dendritic Cells--immunology<br/>Endpoint Determination<br/>Female<br/>Glioblastoma--diagnosis<br/>Humans<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Survival Analysis<br/>Treatment Outcome<br/>Young Adult